Ian F Tannock
Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer
Vera-Badillo F, Tannock I, Bedard P, Goldstein R, Seruga B, Templeton A, Ocana A, Kuruzar G, Chang M, Amir E. Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer. J Clin Pathol 2015
15.06.2015Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer
15.06.2015J Clin Pathol 2015
Vera-Badillo Francisco E, Tannock Ian F, Bedard Philippe L, Goldstein Robyn, Seruga Bostjan, Templeton Arnoud, Ocana Alberto, Kuruzar Gordana, Chang Martin C, Amir Eitan
Influence of censoring on conclusions of trials for women with metastatic breast cancer
Templeton A, Ace O, Amir E, Vera-Badillo F, Ocana A, Pond G, Tannock I. Influence of censoring on conclusions of trials for women with metastatic breast cancer. Eur J Cancer 2015
26.02.2015Influence of censoring on conclusions of trials for women with metastatic breast cancer
26.02.2015Eur J Cancer 2015
Templeton Arnoud, Ace Olga, Amir Eitan, Vera-Badillo Francisco, Ocana Alberto, Pond Gregory R, Tannock Ian F
Use and misuse of waterfall plots
Shao T, Shoushtari H, Sinaei M, Kim T, Margolis M, McNamara M, Vera-Badillo F, Jang R, Templeton A, Wang L, Tannock I. Use and misuse of waterfall plots. J Natl Cancer Inst 2014; 106
29.10.2014Use and misuse of waterfall plots
29.10.2014J Natl Cancer Inst 2014; 106
Shao Tiffany, Shoushtari Hassan, Sinaei Mehrdad, Kim Tae Kyoung, Margolis Myles, McNamara Mairead G, Vera-Badillo Francisco W, Jang Raymond, Templeton Arnoud, Wang Lisa, Tannock Ian F
Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer
Leibowitz-Amit R, Templeton A, Alibhai S, Knox J, Sridhar S, Tannock I, Joshua A. Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer. J Geriatr Oncol 2014; 6:23-8.
07.10.2014Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer
07.10.2014J Geriatr Oncol 2014; 6:23-8
Leibowitz-Amit Raya, Templeton Arnoud, Alibhai Shabbir M, Knox Jennifer J, Sridhar Srikala S, Tannock Ian F, Joshua Anthony M
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone
Leibowitz-Amit R, Alimohamed N, Vera-Badillo F, Seah J, Templeton A, Knox J, Tannock I, Sridhar S, Joshua A. Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone. Prostate 2014; 74:1462-4.
11.08.2014Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone
11.08.2014Prostate 2014; 74:1462-4
Leibowitz-Amit Raya, Alimohamed Nimira, Vera-Badillo Francisco E, Seah Jo-An, Templeton Arnoud, Knox Jennifer J, Tannock Ian F, Sridhar Srikala S, Joshua Anthony M
Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment
Vera-Badillo F, Ocana A, Templeton A, Tibau A, Amir E, Tannock I. Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment. J Clin Oncol 2014; 32:3197.
04.08.2014Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment
04.08.2014J Clin Oncol 2014; 32:3197
Vera-Badillo Francisco E, Ocana Alberto, Templeton Arnoud, Tibau Ariadna, Amir Eitan, Tannock Ian F
Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole
Leibowitz-Amit R, Sridhar S, Tannock I, Knox J, Alimohamed N, Vera-Badillo F, Templeton A, Atenafu E, Seah J, Joshua A. Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole. Eur J Cancer 2014; 50:2399-407.
16.07.2014Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole
16.07.2014Eur J Cancer 2014; 50:2399-407
Leibowitz-Amit Raya, Sridhar Srikala S, Tannock Ian F, Knox Jennifer J, Alimohamed Nimira, Vera-Badillo Francisco E, Templeton Arnoud, Atenafu Eshetu G, Seah Jo-An, Joshua Anthony M
Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio
Templeton A, Tannock I, de Bono J, Attard G, Vera-Badillo F, Leibowitz-Amit R, McNamara M, Omlin A, Pezaro C, Amir E. Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio. Cancer 2014; 120:3346-52.
03.07.2014Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio
03.07.2014Cancer 2014; 120:3346-52
Templeton Arnoud, Tannock Ian F, de Bono Johann S, Attard Gerhardt, Vera-Badillo Francisco E, Leibowitz-Amit Raya, McNamara Mairead G, Omlin Aurelius, Pezaro Carmel, Amir Eitan
Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis
Vera-Badillo F, Napoleone M, Ocana A, Templeton A, Seruga B, Al-Mubarak M, AlHashem H, Tannock I, Amir E. Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 2014; 146:235-44.
14.06.2014Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis
14.06.2014Breast Cancer Res Treat 2014; 146:235-44
Vera-Badillo Francisco E, Napoleone Marc, Ocana Alberto, Templeton Arnoud, Seruga Bostjan, Al-Mubarak Mustafa, AlHashem Hashem, Tannock Ian F, Amir Eitan
Systemic Therapy for Non-clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis
Vera-Badillo F, Escudier B, Tannock I, Knox J, Aneja P, de Gouveia P, Ocana A, Duran I, Templeton A, Amir E. Systemic Therapy for Non-clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis. Eur Urol 2014
29.05.2014Systemic Therapy for Non-clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis
29.05.2014Eur Urol 2014
Vera-Badillo Francisco E, Escudier Bernard, Tannock Ian F, Knox Jennifer J, Aneja Priya, de Gouveia Paulo, Ocana Alberto, Duran Ignacio, Templeton Arnoud, Amir Eitan
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
Templeton A, Tannock I, Tran B, Knox J, Sonpavde G, Leibowitz-Amit R, Ocana A, Aneja P, Vera-Badillo F, Seruga B, McNamara M, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106:dju124.
29.05.2014Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
29.05.2014J Natl Cancer Inst 2014; 106:dju124
Templeton Arnoud, Tannock Ian F, Tran Ben, Knox Jennifer J, Sonpavde Guru, Leibowitz-Amit Raya, Ocana Alberto, Aneja Priya, Vera-Badillo Francisco E, Seruga Bostjan, McNamara Mairead G, Amir Eitan
Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis
Templeton A, Tannock I, Ocana A, Seruga B, Hermanns T, Vera-Badillo F, Al-Mubarak M, McNamara M, Ace O, Amir E. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014; 23:1204-12.
03.05.2014Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis
03.05.2014Cancer Epidemiol Biomarkers Prev 2014; 23:1204-12
Templeton Arnoud, Tannock Ian F, Ocana Alberto, Seruga Bostjan, Hermanns Thomas, Vera-Badillo Francisco E, Al-Mubarak Mustafa, McNamara Mairead G, Ace Olga, Amir Eitan
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
Vera-Badillo F, Ocana A, Tannock I, Seruga B, Al-Mubarak M, Bedard P, Diaz-Padilla I, de Gouveia P, Templeton A, Amir E. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2013; 106:djt319.
22.11.2013Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
22.11.2013J Natl Cancer Inst 2013; 106:djt319
Vera-Badillo Francisco E, Ocana Alberto, Tannock Ian F, Seruga Bostjan, Al-Mubarak Mustafa, Bedard Philippe L, Diaz-Padilla Ivan, de Gouveia Paulo, Templeton Arnoud, Amir Eitan